| 06.12.2024 12:11 | SCLP | IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million | Alliance |
| 05.12.2024 12:39 | SCLP | Result of Placing and Subscription | RNS |
| 04.12.2024 18:03 | SCLP | Retail Offer for up to £1 million | RNS |
| 04.12.2024 17:59 | SCLP | Proposed fundraise in excess of £8.5 million | RNS |
| 04.12.2024 07:00 | SCLP | Second Commercial License Agreement with Genmab | RNS |
| 18.11.2024 15:55 | SCLP | Scancell announces promising findings from cancer drug trial | Alliance |
| 25.10.2024 15:26 | SCLP | Result of Annual General Meeting | RNS |
| 24.10.2024 07:00 | SCLP | Holding(s) in Company | RNS |
| 22.10.2024 07:00 | SCLP | Scancell Appoints Dr Phil L’Huillier as CEO | RNS |
| 18.10.2024 15:40 | SCLP, KCR, IXI | UK shareholder meetings calendar - next 7 days | Alliance |
| 01.10.2024 07:00 | SCLP | Notice of AGM | RNS |
| 24.09.2024 21:29 | EGT, HUM, SCLP | EARNINGS: HSS Hire swings to loss, while Niox profit increases | Alliance |
| 24.09.2024 07:00 | SCLP | Results Year Ended 30 April 2024 | RNS |
| 18.09.2024 07:00 | SCLP | Notice of Final Results | RNS |
| 17.09.2024 07:00 | SCLP | Strategic Partnership with PharmaJet | RNS |
| 02.09.2024 07:00 | SCLP | Scancell to attend upcoming conferences | RNS |
| 30.07.2024 07:17 | SCLP | Scancell Appoints Dr Nermeen Varawalla as CMO | RNS |
| 30.07.2024 07:00 | SCLP | Scancell Appoints Dr Nermeen Varawalla as CMO | RNS |
| 24.07.2024 07:00 | SCLP | Update from iSCIB1+ Clinical Advisory Meeting | RNS |
| 10.07.2024 07:00 | SCLP | Appointment of Dr Florian Reinaud to the Board | RNS |
| 02.07.2024 20:03 | TXP, ECR, HELD | TRADING UPDATES: Creo extends contract; Belluscura raises funds | Alliance |
| 02.07.2024 07:00 | SCLP | Extension of Convertible Loan Notes | RNS |
| 01.07.2024 07:00 | SCLP | Block Listing Return and Total Voting Rights | RNS |
| 21.06.2024 07:00 | SCLP | Change of Nominated Advisor | RNS |
| 12.06.2024 13:13 | SCLP | Shares in Scancell climb as strikes exclusive drug evaluation deal | Alliance |
| 12.06.2024 07:32 | SCLP | Agreement with major biotech | RNS |
| 31.05.2024 07:00 | SCLP | Scancell to attend upcoming conferences | RNS |
| 30.05.2024 07:00 | SCLP | Update on ModiFY trial | RNS |
| 24.05.2024 07:00 | SCLP | Scancell to present at ASCO Annual Meeting | RNS |
| 21.05.2024 07:00 | SCLP | Issue of share options | RNS |
| 16.05.2024 07:00 | SCLP | Presenting at the Sachs 10th Annual Oncology Forum | RNS |
| 09.05.2024 07:00 | SCLP | Scancell presenting at 21st CIMT Annual Meeting | RNS |
| 17.04.2024 07:00 | SCLP | Presenting at the Annual Immuno-Oncology Summit | RNS |
| 16.04.2024 07:00 | SCLP | Block Listing Six Monthly Return | RNS |
| 03.04.2024 07:00 | SCLP | Employee exercise of share options | RNS |
| 02.04.2024 07:00 | SCLP | Scancell to Present at 2024 AACR Annual Meeting | RNS |
| 28.03.2024 13:21 | SCLP | Scancell Appoints WG as Joint Broker | RNS |
| 26.03.2024 14:00 | SCLP | Scancell doses first patient in melanoma-focused trials | Alliance |
| 26.03.2024 12:22 | SCLP | First iSCIB1+ patient dosed | RNS |
| 14.03.2024 11:17 | SCLP | Appointment of Sath Nirmalananthan to the Board | RNS |
| 12.03.2024 07:00 | SCLP | Scancell Attendance at Upcoming Conferences | Reach |
| 04.03.2024 07:00 | SCLP | Presenting at Next-Gen Immuno-Oncology Conference | RNS |
| 20.02.2024 07:00 | SCLP | Change of Auditor | RNS |
| 05.02.2024 14:09 | APH, AGY, SCLP | TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down | Alliance |
| 05.02.2024 07:00 | SCLP | Directorate Change | RNS |
| 30.01.2024 13:56 | SCLP | Scancell interim loss narrows amid finance gain on derivative | Alliance |
| 30.01.2024 07:00 | SCLP | Interim Results | RNS |
| 26.01.2024 07:00 | SCLP | Notice of Interim Results and Presentation | RNS |
| 17.01.2024 14:26 | SCLP | IN BRIEF: Scancell approved by MHRA to add new cohort to Scope trial | Alliance |
| 17.01.2024 13:46 | SCLP | Update on SCOPE trial | RNS |
| 28.12.2023 17:36 | SCLP | Holding(s) in Company | RNS |
| 27.12.2023 11:38 | SCLP | Holding(s) in Company | RNS |
| 19.12.2023 13:35 | SCLP | Scancell raises GBP12 million in total from fundraise | Alliance |
| 19.12.2023 07:00 | SCLP | Result of the Open Offer | RNS |
| 06.12.2023 12:41 | SCLP | PDMR Notification | RNS |
| 01.12.2023 09:54 | SCLP | IN BRIEF: Scancell raises GBP10.7 million in upsized share sale | Alliance |
| 01.12.2023 07:00 | SCLP | Results of Placing | RNS |
| 30.11.2023 21:10 | SCLP, ONDO, ZEN | EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen | Alliance |
| 30.11.2023 17:03 | SCLP | Proposed Capital Raise to raise approximately £6m | RNS |
| 29.11.2023 14:35 | SCLP | Result of AGM | RNS |
| 28.11.2023 14:57 | OPTI, ZEN, OMI | TRADING UPDATES: Scancell trial progresses; OptiBiotix inks new deal | Alliance |
| 28.11.2023 07:00 | SCLP | Update on SCOPE trial | RNS |
| 22.11.2023 15:53 | VAST, TRT, THR | UK shareholder meetings calendar - next 7 days | Alliance |
| 10.11.2023 11:14 | SCLP | IN BRIEF: Scancell shares up as presents "trailblazing" trial data | Alliance |
| 10.11.2023 08:32 | SCLP | Scancell to present at 20th SMR Congress | RNS |
| 01.11.2023 07:00 | SCLP | Scancell to present at 38th Annual SITC meeting | RNS |
| 31.10.2023 14:45 | FIPP, SCLP, ESYS | EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss | Alliance |
| 31.10.2023 12:00 | SCLP | Notice of AGM | RNS |
| 31.10.2023 07:00 | SCLP | Results for the Year Ended 30 April 2023 | RNS |
| 20.10.2023 09:00 | SCLP | IN BRIEF: Scancell says needs more time to publish annual results | Alliance |
| 20.10.2023 07:00 | SCLP | Update on Final Results | RNS |
| 18.10.2023 07:00 | SCLP | Scancell to speak at World Vaccine Congress Europe | RNS |
| 17.10.2023 15:43 | WPS, TRI, TPK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 17.10.2023 07:00 | SCLP | Block Listing Six Monthly Return | RNS |
| 11.10.2023 07:00 | SCLP | Change of Date for Final Results | RNS |
